Christoph Heuck, M.D.

Dr. Christoph Heuck is a an assistant professor of Medicine at the Myeloma Institute for Research & Therapy.  He completed a hematology/oncology fellowship at Montefiore Medical Center and an Internal Medicine residency at Jacobi Medical Center, both in New York. Dr. Heuck is board certified by the American Board of Internal Medicine. He received his medical degree in 2003 from Humboldt University in Berlin, graduating magna cum laude.Heuck_Christoph_MD_MIRTweb

Dr. Heuck has conducted research related to molecular genetics of multiple myeloma and other cancers.  He is board certified in Internal Medicine and board eligible in Hematology and Oncology.  Dr. Heuck is a member of the American College of Physicians, American Medical Association, American Society of Clinical Oncologists and American Society of Hematology.

 Professional Certifications and Education
  • American Board of Internal Medicine, 2007
  • Fellowship: Hematology/Oncology, Montefiore Medical Center, New York
  • Residency: Internal Medicine, Jacobi Medical Center, New York
  • University: M.D. DEGREE: Humboldt University, Berlin, Germany


  • Multiple Myeloma
  • Myeloma & Transplantation
  • MGUS
  • Smoldering Myeloma

Conditions/Diseases Treated

UAMS doctors treat a broad range of conditions some of which may not be listed below.

  • Multiple Myeloma
  • Smoldering Myeloma
  • MGUS
  • Waldenstrom Macroglobulinemia
  • Amyloidosis
  • MDS

Languages Spoken

  • English
  • German

Medical Interpreters are available to help patients communicate with hospital and clinic staff. Other services available is translation of patient education materials and hospital forms. For more information, please contact interpreting services at 501-395-8231 or visit us on the web.

Additional Links

Invited Guest Speaker :

LEUKEMIA AND LYMPHOMA – East and West are together

Dubrovnik, Croatia, September 17 – 21, 2011

The Molecular Pathogenesis of Multiple Myeloma

 IMF workshop
Little Rock, AR, May 5th 2012

Maintenance Therapy in Multiple Myeloma


Leukemia and Lymphoma Society Translational Research Program

“Targeting DNA methylation in the diagnosis and therapy of high-risk myeloma”

October 1st, 2012 – September 30th, 2015

Hospital Affiliations

  • University of Arkansas for Medical Sciences

Institute Affiliations

  • Myeloma Institute for Research and Therapy

Academic Appointment

  • Assistant Professor of Medicine